SAT-216 Prevalence of Endocrine, Gynecological and Other Medical Conditions Among Adult Women with Turner Syndrome

por Farquhar, Madeleine, Allen, Lisa, Jacobson, Michelle, Wolfman, Wendy, Kelly, Catherine, Lega, Iliana
Publicado 2019

Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial

por Neal-Perry, Genevieve, Cano, Antonio, Lederman, Samuel, Nappi, Rossella E., Santoro, Nanette, Wolfman, Wendy, English, Marci, Franklin, Catherine, Valluri, Udaya, Ottery, Faith D.
Publicado 2023

OR06-5 Fezolinetant for Treatment of Moderate-to-severe Vasomotor Symptoms Associated with Menopause: Results from a 52-week Study (Skylight 2)

por English, Marci, Franklin, Catherine, Johnson, Kimball, Lee, Misun, Nappi, Rossella E, Ottery, Faith, Santoro, Nanette, Shapiro, Marla, Stute, Petra, Thurston, Rebecca C, Wolfman, Wendy, Neal-Perry, Genevieve
Publicado 2022

Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT

por Johnson, Kimball A, Martin, Nancy, Nappi, Rossella E, Neal-Perry, Genevieve, Shapiro, Marla, Stute, Petra, Thurston, Rebecca C, Wolfman, Wendy, English, Marci, Franklin, Catherine, Lee, Misun, Santoro, Nanette
Publicado 2023